Marantz Jing L. — SEC insider filings

SEC reporting owner CIK 1834528. 21 insider filings on record with FilingPulse; latest filed 2026-10-28.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2021-01-05 to 2026-10-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Scholar Rock Holding Corp (SRRK)CHIEF MEDICAL OFFICER10—12 legs · 135,610 sh · $4,056,63214
Arcturus Therapeutics Holdings Inc. (ARCT)Director6——10
Krystal Biotech, Inc. (KRYS)Chief Business Officer3——3
Intellia Therapeutics, Inc. (NTLA)EVP, Chief Medical Officer2——2

Insider filings — Marantz Jing L.

FiledFormIssuerReported transactionsSource
2026-10-283Intellia Therapeutics, Inc. (NTLA)Holdings only — no transactions reportedEDGAR
2026-10-284Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 199,822 @ $0 · Grant/award (A): 275,061 (derivative) @ $0EDGAR
2026-06-154Arcturus Therapeutics Holdings Inc. (ARCT)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2026-02-194Scholar Rock Holding Corp (SRRK)Sale (S): 4,157 @ $46.53EDGAR
2026-02-114Scholar Rock Holding Corp (SRRK)Grant/award (A): 34,482 @ $0EDGAR
2026-01-214Scholar Rock Holding Corp (SRRK)Sale (S): 5,798 @ $44.48EDGAR
2025-06-114Arcturus Therapeutics Holdings Inc. (ARCT)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2025-03-124Scholar Rock Holding Corp (SRRK)Grant/award (A): 34,285 @ $0 · Grant/award (A): 45,715 (derivative) @ $0EDGAR
2025-01-214Scholar Rock Holding Corp (SRRK)Sale (S): 5,655 @ $44.20EDGAR
2024-11-264Scholar Rock Holding Corp (SRRK)Option exercise (M): 2,145 @ $8.59 · Sale (S): 2,145 @ $30.01 · Option exercise (M): 6,375 @ $8.59 · Sale (S): 1,000 @ $38.04 · Sale (S): 2,100 @ $39.25 · Sale (S): 3,075 @ $39.93 · +3 moreEDGAR
2024-11-134Scholar Rock Holding Corp (SRRK)Option exercise (M): 2,105 @ $8.59 · Sale (S): 2,105 @ $30.00 · Option exercise (M): 2,105 (derivative) @ $0EDGAR
2024-10-074Scholar Rock Holding Corp (SRRK)Option exercise (M): 109,375 @ $8.59 · Sale (S): 67,448 @ $25.59 · Sale (S): 2,552 @ $26.22 · Sale (S): 39,375 @ $30.06 · Option exercise (M): 109,375 (derivative) @ $0EDGAR
2024-06-184Arcturus Therapeutics Holdings Inc. (ARCT)Option exercise (M): 3,131 @ $0 · Option exercise (M): 3,131 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-02-134Scholar Rock Holding Corp (SRRK)Grant/award (A): 72,855 @ $0 · Grant/award (A): 97,145 (derivative) @ $0EDGAR
2023-08-034Arcturus Therapeutics Holdings Inc. (ARCT)Grant/award (A): 11,869 (derivative) @ $0 · Grant/award (A): 3,131 (derivative) @ $0EDGAR
2022-11-154Scholar Rock Holding Corp (SRRK)Grant/award (A): 250,000 (derivative) @ $0EDGAR
2022-06-274Arcturus Therapeutics Holdings Inc. (ARCT)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-01-314Krystal Biotech, Inc. (KRYS)Grant/award (A): 205,000 (derivative) @ $0EDGAR
2021-12-094Arcturus Therapeutics Holdings Inc. (ARCT)Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 6,699 (derivative) @ $0EDGAR
2021-07-024Krystal Biotech, Inc. (KRYS)Grant/award (A): 6,800 (derivative) @ $0EDGAR
2021-01-054Krystal Biotech, Inc. (KRYS)Grant/award (A): 13,600 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1834528 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs